My research combines structural and functional brain imaging with statistical and network-level analysis to study healthy and diseased populations.
We combine these imaging techniques with comprehensive behavioural phenotyping to identify brain substrates underlying individual differences in cognition and affect.
In neurological and neurodevelopmental disorders, particularly epilepsy and autism spectrum disorders, we develop in-vivo methodologies to profile individual patients and to predict future disease trajectories and clinically relevant outcomes prospectively.